BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 3908145)

  • 1. Blood transfusions generate/increase previously absent/weak blocking antibody in women with habitual abortion.
    Unander AM; Lindholm A; Olding LB
    Fertil Steril; 1985 Dec; 44(6):766-71. PubMed ID: 3908145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transfusions of leukocyte-rich erythrocyte concentrates: a successful treatment in selected cases of habitual abortion.
    Unander AM; Lindholm A
    Am J Obstet Gynecol; 1986 Mar; 154(3):516-20. PubMed ID: 3953699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opinions on treatment of women with habitual abortion based on investigations for blocking antibody and autoantibodies.
    Unander AM; Norberg R; Arfors L; Enskog A; Haeger M; Lindholm A; Robbins D; Siösteen C; Söderström T; Stigendal L
    Am J Reprod Immunol; 1991 Aug; 26(1):32-7. PubMed ID: 1835842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dialyzable serum factors after cellular immunity in pregnancy.
    Szekeres J; Fabian G; Pacsa AS; Pejtsik B
    Experientia; 1981 May; 37(5):515-6. PubMed ID: 7018923
    [No Abstract]   [Full Text] [Related]  

  • 5. [Comparative study of the third party and paternal leukocyte immunization in recurrent spontaneous abortion of lowered maternal-fetal immuno-recognition].
    Li D; Li C; Zhu Y
    Zhonghua Fu Chan Ke Za Zhi; 1998 Oct; 33(10):597-600. PubMed ID: 10806684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The results of investigations for blocking antibody and autoantibodies help to choose between different immunological treatments for recurrent abortion.
    Unander AM; Norberg R; Wenneström H; Siösteen C; Lindholm A; Stigendal L; Haeger M; Arfors L
    Acta Eur Fertil; 1989; 20(4):193-8. PubMed ID: 2535267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prevention of habitual abortion by buffycoat transfusions].
    Neumeyer H; Kuhn W; Götze O; Hinney B
    Z Geburtshilfe Perinatol; 1985; 189(5):197-201. PubMed ID: 4072314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of recurrent spontaneous abortions by leukocyte transfusions.
    Taylor CG; Faulk WP; McIntyre JA
    J R Soc Med; 1985 Aug; 78(8):623-7. PubMed ID: 4020795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interpretation of blocking activity in maternal serum depends on the equation used for calculation of mixed lymphocyte culture results.
    Park MI; Edwin SS; Scott JR; Branch DW
    Clin Exp Immunol; 1990 Nov; 82(2):363-8. PubMed ID: 2146996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of MLR-Bf and protection of fetal loss: a current double blind randomized trial of paternal lymphocyte immunization for women with recurrent spontaneous abortion.
    Pandey MK; Agrawal S
    Int Immunopharmacol; 2004 Feb; 4(2):289-98. PubMed ID: 14996420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory serum factor of lymphoproliferative response to allogeneic cells in pregnancy.
    Daher S; Fonseca F; Mattar R; Musatti CC; de Lima MG
    Sao Paulo Med J; 1997; 115(4):1485-9. PubMed ID: 9595813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immuno-epidemiological investigation of recurrent spontaneous abortion].
    Li D; Zhu Y; Wang M
    Zhonghua Yi Xue Za Zhi; 1998 Feb; 78(2):94-7. PubMed ID: 10923415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mixed lymphocyte reaction blocking factors (MLR-Bf) as potential biomarker for indication and efficacy of paternal lymphocyte immunization in recurrent spontaneous abortion.
    Khonina NA; Broitman EV; Shevela EY; Pasman NM; Chernykh ER
    Arch Gynecol Obstet; 2013 Oct; 288(4):933-7. PubMed ID: 23558562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of CD4(+)CD25(+)CD127(-) regulatory T cells with MLC-BE and BE-Ab2: an efficient evaluation of the therapy of paternal lymphocyte induced immunization in unexplained recurrent spontaneous abortion patients.
    Yuan MM; Du MR; Wang MY; Duan ZL; Meng Y; Jin LP; Li MQ; Li DJ
    Int J Clin Exp Pathol; 2015; 8(4):4022-32. PubMed ID: 26097590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on the maternal immune response to placental antigens: absence of a blocking factor from the blood of abortion-prone women.
    Stimson WH; Strachan AF; Shepherd A
    Br J Obstet Gynaecol; 1979 Jan; 86(1):41-5. PubMed ID: 760765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphocyte immunization generates immunosuppressive factors in women with recurrent abortions.
    Fizet D; Bouzgarrou R; Vezon G
    Gynecol Obstet Invest; 1990; 30(1):8-11. PubMed ID: 2146198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Female third party lymphocytes are effective for immunotherapy of patients with unexplained primary recurrent spontaneous abortion: A retrospective analysis of outcomes.
    Liang X; Qiu T; Qiu L; Wang X; Zhao A; Lin Q
    Eur J Contracept Reprod Health Care; 2015; 20(6):428-37. PubMed ID: 25985825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Idiopathic habitual abortion: experiences with active immunotherapy].
    Sterzik K; Strehler E; De Santo M; Oblinger E; Rosenbusch B; Kreienberg R
    Geburtshilfe Frauenheilkd; 1995 Sep; 55(9):493-9. PubMed ID: 7498716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maternal-fetal relation. Absence of an immunologic blocking factor from the serum of women with chronic abortions.
    Rocklin RE; Kitzmiller JL; Carpenter CB; Garovoy MR; David JR
    N Engl J Med; 1976 Nov; 295(22):1209-13. PubMed ID: 790183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Easily suppressed lymphocytes and absence of cytotoxic antibody in three women with habitual abortion.
    Unander AM; Olding LB
    Am J Reprod Immunol (1980); 1982 Oct; 2(5):254-9. PubMed ID: 7180949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.